Nomura Research Institute, Ltd.
Nomura Research Institute, Ltd. (NRILY) Financial Performance & Income Statement Overview
Analyze Nomura Research Institute, Ltd. (NRILY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Nomura Research Institute, Ltd. (NRILY) Income Statement & Financial Overview
Analyze Nomura Research Institute, Ltd.’s NRILY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $196.57B | $191.47B | $188.67B | $188.11B |
| Cost of Revenue | $126.86B | $120.60B | $121.61B | $120.45B |
| Gross Profit | $69.71B | $70.86B | $67.06B | $67.66B |
| Gross Profit Ratio | $0.35 | $0.37 | $0.36 | $0.36 |
| R&D Expenses | $1.60B | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $35.98B | $33.47B | $35.08B | $36.47B |
| Operating Expenses | $37.57B | $34.15B | $35.08B | $35.02B |
| Total Costs & Expenses | $164.43B | $154.75B | $156.68B | $155.47B |
| Interest Income | $1.24B | $0.00 | $1.55B | $1.34B |
| Interest Expense | $1.22B | $0.00 | $1.15B | $1.93B |
| Depreciation & Amortization | $12.30B | $12.12B | $12.21B | $12.28B |
| EBITDA | $45.95B | $48.40B | $46.58B | $44.77B |
| EBITDA Ratio | $0.23 | $0.25 | $0.25 | $0.24 |
| Operating Income | $32.14B | $36.72B | $31.98B | $32.64B |
| Operating Income Ratio | $0.16 | $0.19 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | $292.00M | -$567.00M | $1.22B | -$594.00M |
| Income Before Tax | $32.43B | $36.15B | $33.21B | $32.05B |
| Income Before Tax Ratio | $0.16 | $0.19 | $0.18 | $0.17 |
| Income Tax Expense | $10.39B | $9.88B | $9.79B | $9.72B |
| Net Income | $21.97B | $26.14B | $23.49B | $22.17B |
| Net Income Ratio | $0.11 | $0.14 | $0.12 | $0.12 |
| EPS | $38.41 | $45.73 | $40.93 | $38.51 |
| Diluted EPS | $38.41 | $45.73 | $40.93 | $38.50 |
| Weighted Avg Shares Outstanding | $571.89M | $571.64M | $573.81M | $575.74M |
| Weighted Avg Shares Outstanding (Diluted) | $571.89M | $571.63M | $573.81M | $575.70M |
The company's financials show resilient growth, with revenue advancing from $188.11B in Q1 2024 to $196.57B in Q4 2024. Gross profit remained healthy with margins at 35% in Q4 2024 compared to 36% in Q1 2024. Operating income hit $32.14B last quarter, sustaining a consistent 16% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $45.95B. Net income dropped to $21.97B, while earnings per share reached $38.41. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan